Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Open Access Gold |
|
as soon as is submitted to ZB.
Editorial: Translational research for better diagnosis and treatment of endometrial cancer.
Front. Oncol. 13:1305140 (2023)
Publication type
Article: Journal article
Document type
Editorial
Keywords
Biomarkers ; Endometrial Cancer ; Gynaecology ; Metabolomics ; Omics ; Proteomics
Language
english
Publication Year
2023
HGF-reported in Year
2023
ISSN (print) / ISBN
2234-943X
e-ISSN
2234-943X
Journal
Frontiers in Oncology
Quellenangaben
Volume: 13,
Article Number: 1305140
Publisher
Frontiers
Publishing Place
Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Reviewing status
Peer reviewed
Institute(s)
Institute of Diabetes and Cancer (IDC)
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502594-001
Grants
Slovenian Research Agency
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by project J3-2535 from the Slovenian Research Agency to TLR.
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by project J3-2535 from the Slovenian Research Agency to TLR.
WOS ID
001096282900001
Scopus ID
85175708906
PubMed ID
37927477
Erfassungsdatum
2023-11-28